Achieve Life Sciences (ACHV) Reports In-Line Q4 EPS

Achieve Life Sciences (NASDAQ: ACHV) reported Q4 EPS of ($0.28), in-line with the analyst estimate of ($0.28).

For earnings history and earnings-related data on Achieve Life Sciences (ACHV) click here.

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• HSBC Upgrades Pegatron Corp. (4938:TT) to Hold
• Citi sees Birkenstock EPS beat, guidance lift on FX and lower share count